Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of Neoadjuvant Chemotherapy on Complications, in-Hospital Mortality, Length of Stay and Total Hospital Costs in Bladder Cancer Patients Undergoing Radical Cystectomy.
Hoeh B, Flammia RS, Hohenhorst L, Sorce G, Chierigo F, Panunzio A, Tian Z, Saad F, Gallucci M, Briganti A, Terrone C, Shariat SF, Graefen M, Tilki D, Antonelli A, Kluth LA, Mandel P, Chun FKH, Karakiewicz PI. Hoeh B, et al. Among authors: chierigo f. Cancers (Basel). 2022 Feb 26;14(5):1222. doi: 10.3390/cancers14051222. Cancers (Basel). 2022. PMID: 35267529 Free PMC article.
Pattern of Biopsy Gleason Grade Group 5 (4 + 5 vs 5 + 4 vs 5 + 5) Predicts Survival After Radical Prostatectomy or External Beam Radiation Therapy.
Wenzel M, Würnschimmel C, Chierigo F, Mori K, Tian Z, Terrone C, Shariat SF, Saad F, Tilki D, Graefen M, Mandel P, Roos FC, Chun FKH, Karakiewicz PI. Wenzel M, et al. Among authors: chierigo f. Eur Urol Focus. 2022 May;8(3):710-717. doi: 10.1016/j.euf.2021.04.011. Epub 2021 Apr 28. Eur Urol Focus. 2022. PMID: 33933420
Presence of biopsy Gleason pattern 5 + 3 is associated with higher mortality after radical prostatectomy but not after external beam radiotherapy compared to other Gleason Grade Group IV patterns.
Würnschimmel C, Wenzel M, Chierigo F, Flammia RS, Mori K, Tian Z, Shariat SF, Saad F, Briganti A, Suardi N, Terrone C, Gallucci M, Chun FKH, Tilki D, Graefen M, Karakiewicz PI. Würnschimmel C, et al. Among authors: chierigo f. Prostate. 2021 Aug;81(11):778-784. doi: 10.1002/pros.24175. Epub 2021 May 31. Prostate. 2021. PMID: 34057220
Assessment of the optimal number of positive biopsy cores to discriminate between cancer-specific mortality in high-risk versus very high-risk prostate cancer patients.
Wenzel M, Würnschimmel C, Chierigo F, Tian Z, Shariat SF, Terrone C, Saad F, Tilki D, Graefen M, Roos FC, A Kluth L, Mandel P, Chun FKH, Karakiewicz PI. Wenzel M, et al. Among authors: chierigo f. Prostate. 2021 Oct;81(14):1055-1063. doi: 10.1002/pros.24202. Epub 2021 Jul 26. Prostate. 2021. PMID: 34312910
Nomogram Predicting Downgrading in National Comprehensive Cancer Network High-risk Prostate Cancer Patients Treated with Radical Prostatectomy.
Wenzel M, Würnschimmel C, Chierigo F, Flammia RS, Tian Z, Shariat SF, Gallucci M, Terrone C, Saad F, Tilki D, Graefen M, Becker A, Kluth LA, Mandel P, Chun FKH, Karakiewicz PI. Wenzel M, et al. Among authors: chierigo f. Eur Urol Focus. 2022 Sep;8(5):1133-1140. doi: 10.1016/j.euf.2021.07.008. Epub 2021 Jul 30. Eur Urol Focus. 2022. PMID: 34334344
93 results